Avastin for Prostate Cancer – Looks Like It Isn’t Going To Happen
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]
The FDA Has Approved TRELSTAR(R) 22.5 mg, The First 6-Month GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice a year. […]
HERO: EXTRA HAM
This just makes me smile. Perhaps it will do the same for you. Just let it load (or click the words "slow progress?" to go to the site) and enjoy the theatrics. This post is a limited engagement so catch it while you can!
Death Due to Competing Risks in Men with Metastatic Prostate Cancer
The old adage, prostate cancer is the cancer that you die with not the cancer you die from has been around for a long time. No question compared too many other cancers prostate cancer does progress more slowly than many other cancers. But, is this adage true? Men with prostate cancer have competing mortality risks [...]
Ron Gerhard Speaks About the American Cancer Society & PSA Testing
There has been a lot of criticism about the recent guidelines on PSA testing that has been issued by the American Cancer Society (ACS). Many of us with advanced prostate cancer are appalled with these guidelines and feel it is just another example of the ACS abandoning men with cancer over the powerful breast cancer [...]